Clay Siegall & The Future of Cancer Fighting Biotechnology

When it comes to illnesses in today’s society, Cancer is one of the worlds most prevalent diseases. These deadly cells can manifest and grow throughout the years in the human in areas such as lungs, pancreas, liver, throat, etc. There have been many treatments for cancer, but none of them has really made a large enough dent to in saving lives. As of 2016, cancer treatment is far more advanced and precise. Antibody Based Therapies are some of the most successful treatments for fighting the illness and destroying the dangerous cells on contact. One of the leading Biotech Companies in the world is Seattle Genetics and this company is changing the current status quo.

Seattle Genetics stands out from the competitors thanks to it’s advanced cancer fighting capabilities, scientific innovation, development, and commercialization of medications. Seattle Genetics has one of the best leaders in the industry as well and it’s his guidance that has pushed the organization to the apex of the field. Clay Siegall is his name and eradicating cancer is his game. This doctor/scientist has knowledge, know-how, expertise, and skill to get the job done and he has a long resume of success to back up all claims. The George Washington University and University of Maryland Graduate has extensive education as Siegall holds a Ph.D in Genetics and a (BS) in Zoology. On top of that, the good doctor holds at least 15 patents of his own and is the author of more than 70 publications. Clay Siegall’s leadership and experience in the game is what help makes him so valuable.

The company’s flagship medicine (ADCETRIS) is one of the most successful at fighting cancerous cells within the body. With this success, the medicines are now available in over 60 countries worldwide. As of the year 2016, Seattle Genetics’ net worth is estimated at $4.7 Billion and Dr. Clay Siegall is in firm control as he continues to steer the ship to future success.When it comes to illnesses in today’s society, Cancer is one of the worlds most prevalent diseases. These deadly cells can manifest and grow throughout the years in the human in areas such as lungs, pancreas, liver, throat, etc. There have been many treatments for cancer, but none of them has really made a large enough dent to in saving lives. As of 2016, cancer treatment is far more advanced and precise. Antibody Based Therapies are some of the most successful treatments for fighting the illness and destroying the dangerous cells on contact. One of the leading Biotech Companies in the world is Seattle Genetics and this company is changing the current status quo.

The company’s flagship medicine (ADCETRIS) is one of the most successful at fighting cancerous cells within the body. With this success, the medicines are now available in over 60 countries worldwide. As of the year 2016, Seattle Genetics’ net worth is estimated at $4.7 Billion and Dr. Clay Siegall is in firm control as he continues to steer the ship to future success.